Atlas Trials

A Study to Learn How Well a Higher Amount of Aflibercept Given as an Injection Into the Eye Works and How Safe it is in People With Reduced Vision Due to Swelling in the Macula, Central Part of the Retina Caused by a Blocked Vein in the Retina (Macula Edema Secondary to Retinal Vein Occlusion)

Clinical trial NCT05850520 · COMPLETED

Trial details

NCT number
NCT05850520
Sponsor
Bayer
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Macular Edema Secondary to Retinal Vein Occlusion
Start date
2023-05-15
Primary completion
2024-11-07
Enrollment
892

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.